HIAL
MRNA icon

Highland Investment Advisors LLC’s Moderna MRNA Stock Holding History

Highland Investment Advisors LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70 Buy
+1
New +$52 ﹤0.01% 707

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Highland Investment Advisors LLC's MRNA Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Moderna (MRNA) in Q2 2026: 1 share worth $70. The stake represents ﹤0.01% of the portfolio and ranks #707 among its holdings.

612 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Highland Investment Advisors LLC held 1 share of Moderna worth $70 as of Q2 2026.
  • Moderna was a new Highland Investment Advisors LLC position in Q2 2026.
  • Moderna made up ﹤0.01% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #707 holding.
  • 612 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.